NUFORMIX PLC

Earnings Release • Sep 30, 2017

Levrett Plc

("Levrett" or the "Company")

Interim Results

for the period ended 30 September 2017

Levrett, a company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, announces its interim results for the period ended 30 September 2017.

For further information please contact:

Levrett plc	+44 (0)20 7183 4342
John Lidgey - Chairman
Whitman Howard Limited	+44 (0)20 7659 1234
Financial Advisor to Levrett
Nick Lovering
Gable Communications Ltd John Bick	+44 (0)20 7193 7463
	levrett@gablecommunications.com

CHAIRMAN'S STATEMENT FOR THE PERIOD ENDED 30 September 2017

Introduction

These are the results for Levrett Plc for the interim period ended 30 September 2017.

The company was incorporated on 10 June 2015 and was admitted to the Official List of the UK Listing Authority on 17 December 2015.

Financial review

In the six months to 30 September 2017, the Company recorded a loss for the period of £77,504 (a loss per share of 0.08 pence). This includes certain fees in relation to the identification of Nuformix Limited as a possible acquisition target, due diligence and advisory fees related to the transaction.

F J Lidgey

Chairman

13 October 2017

INTERIM STATEMENT OF COMPREHENSIVE INCOME FOR THE PERIOD ENDED 30 September 2017

	Unaudited period ended 30 September 2017 £	Unaudited period ended 30 September 2016 £	Audited year ended 31 March 2017 £
Revenue	-	-	-
Administrative expenses	(77,504)	(510,957)	(685,057)
LOSS BEFORE TAX	(77,504)	(510,957)	(685,057)
Tax	-	-	-
LOSS FOR THE PERIOD	(77,504)	(510,957)	(685,057)
Other comprehensive income/(expense)	-	-	-
TOTAL COMPREHENSIVE EXPENSE FOR THE PERIOD	(77,504)	(510,957)	(685,057)

Loss before tax and total comprehensive expense for the period are all attributable to the equity shareholders of the company.

Loss per share
Basic and diluted (pence)	(0.08) p	(0.53) p	(0.72) p

INTERIM STATEMENT OF FINANCIAL POSITION FOR THE PERIOD ENDED 30 September 2017

		Unaudited 30 September	Unaudited 30 September	Audited 31 March
		2017	2016	2017
	Notes	£	£	£
ASSETS
Current assets
Trade and other receivables		142,556	35,310	13,727
Cash and cash equivalents		699	111,358	5,895
		143,255	146,668	19,622
TOTAL ASSETS		143,255	146,668	19,622
EQUITY AND LIABILITIES
Equity
Share capital	3	95,750	95,750	95,750
Share premium account		737,440	734,315	737,440
Share Option Reserve		22,695	22,695	22,695
Retained earnings		(1,112,981)	(861,376)	(1,035,477)
Total equity attributable to equity holders of the parent		(257,096)	(8,616)	(179,592)
Current liabilities
Trade and other payables		400,351	155,284	199,214
TOTAL LIABILITIES		400,351	155,284	199,214
TOTAL EQUITY AND LIABILITIES		143,255	146,668	19,622

INTERIM STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED 30 September 2017

	Share	Share Premium	Share	Retained
	capital	account	Option Reserve	earnings	Total
	£	£	£	£	£
On Incorporation	-	-	-	-	-
Total comprehensive expense to date Shares issued	- 95,750	- 734,315	- 22,695	(861,376) -	(861,376) 852,760
Unaudited at 30 September 2016	95,750	734,315	22,695	(861,376)	(8,616)
Total comprehensive expense to 31 March 2017 Grant of share options	- -	- 3,125	- -	(174,101) -	(174,101) 3,125
Audited at 31 March 2017	95,750	737,440	22,695	(1,035,477)	(179,592)
Total comprehensive expense for period Shares issued	- -	- -	- -	(77,504) -	(77,504) -
Unaudited at 30 September 2017	95,750	737,440	22,695	(1,112,981)	(257,096)

All equity is attributable to equity shareholders of the company.

Share premium

Represents amounts subscribed for share capital in excess of its nominal value, net of directly attributable issue costs.

INTERIM STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 30 September 2017

	Unaudited period ended 30 September 2017 £	Unaudited period ended 30 September 2016 £	Audited Year ended 31 March 2017 £
Operating activities
Loss before tax	(77,504)	(510,957)	(685,057)
Changes in working capital: Share Issue, option of warrants	-	-	3,125
(Increase)/ Decrease in trade and other receivables	(128,829)	7,268	28,851
Increase in trade and other payables	201,137	112,834	156,763
Net cash used in operating activities	(5,196)	(390,855)	(496,318)
Financing activities Share issue	-	-	-
Net cash generated from financing activities	(5,196)	(390,855)	(496,318)
Taxation	-	-	-
Net decrease in cash and cash equivalents	(5,196)	(390,855)	(496,318)
Cash and cash equivalents at the start of the period	5,895	502,213	502,213
Cash and cash equivalents at the end of the period	699	111,358	5,895

NOTES TO THE INTERIM FINANCIAL INFORMATION FOR THE PERIOD ENDED 30 September 2017

1 General information

Levrett Plc is a publicly listed company incorporated and domiciled in England. The address of its registered office is Suite 31, 2nd Floor, 107 Cheapside, London. EC2V 6DN.

The Company is listed on the Official List.

This interim financial information was approved for issue on 13 October 2017.

2 Accounting policies

2.1 Basis of preparation

The interim financial information comprises the Statements of Financial Position at 30 September 2017, the Statements of Comprehensive Income, Changes in Equity and Cash Flows for the period ended 30 September 2017 and the related notes of Levrett Plc, (hereinafter referred to as "the interim financial information").

The interim financial information has been prepared in accordance with IAS 34, 'Interim Financial Reporting' as adopted by the European Union. In preparing this information, management have used the accounting policies set by the Company. The auditors' report on the full statutory accounts for the year ended 31 March 2017 included an Emphasis of Matter paragraph with regards to going concern. The accounts for the year ended 31 March 2017 have been filed with the Registrar of Companies.

This interim financial information does not constitute a set of statutory accounts under the requirements of the Companies Act 2006 and is neither audited nor reviewed.

This document (the Interim Statement 2017) will be published on the company's website and will be publicly available from the London Stock Exchange regulatory publications. The maintenance and integrity of the Levrett Plc website is the responsibility of the directors. Legislation in the UK governing the preparation and dissemination of accounts may differ from legislation in other jurisdictions.

2.2 Going concern

These financial statements have been prepared on the going concern basis based on the current cash flow projections for the following twelve months. In particular, the directors have assumed that the acquisition of Nuformix Limited and the placing of ordinary shares will be approved by the Company's shareholders on 13 October 2017.

NOTES TO THE INTERIM FINANCIAL INFORMATION FOR THE PERIOD ENDED 30 September 2017

3	Share capital Issued and fully paid	Unaudited period ended 30 September 2017 £	Unaudited period ended 30 September 2016 £	Audited year ended 31 March 2017 £
	95,750,000 Ordinary shares issued of £0.001 each	95,750	95,750	95,750
		95,750	95,750	95,750

On Admission to the Official List, 45,750,000 of the above issued share capital was placed at a price of £0.02 per share with the premium (net of the issue costs) being shown in the share premium account.

4 Dividends paid and proposed

Equity dividends on ordinary shares:

No interim dividend was paid or is proposed for the period ended 30 September 2017.

5 Loss per share

The calculations of loss per share are based on the following results and number of shares:

	Unaudited period ended 30 September 2017 £	Unaudited period ended 30 September 2016 £	Audited year ended 31 March 2017 £
Loss for the financial period	(77,504)	(510,957)	(685,057)
Weighted average number of shares for diluted loss per share	95,750,000	95,750,000	95,750,000

At 30 September 2017, the number of ordinary shares in issue was 95,750,000.

DIRECTORS AND OFFICERS

Directors Secretary Company Number Registered office	P D Hughes F J Lidgey A H Reeves St James Corporate Services Limited 09632100 Suite 31 2 nd Floor, 107 Cheapside London EC2V 6DN www.levrett.com
Broker & Corporate Broker	Whitman Howard Limited 1 st Floor, Connaught House 1-3 Mount Street London W1K 3NB
Auditors	haysmacintyre 26 Red Lion Square London WC1R 4AG
Solicitors	Shakespeare Martineau LLP One America Square Crosswall London EC3N 2SG
Registrars	Capita Registrars Limited The Registry 34 Beckenham Road Beckenham Kent BR3 4TU